🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

55 results for “intervention” Clear

  1. Multi-component Interventions

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Multimorbidity

    other active

    1 trial
  2. Multi-component intervention package

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Multimorbidity

    other completed

    1 trial
  3. Nutrition Intervention

    The First People's Hospital of Lianyungang

    Gastric Cancer

    other active

    1 trial
  4. active tDCS and cognitive training intervention

    United Therapeutics Europe Ltd

    Brain Concussion

    other active

    2 trials
  5. cipher prescription 1

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Percutaneous Coronary Artery Intervention

    small molecule completed

    1 trial
  6. multi-factorial intervention

    United Therapeutics Europe Ltd

    Type 2 Diabetes Mellitus

    small molecule active

    1 trial
  7. multi-intervention program and protein foods supplementation

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Sarcopenia

    other completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources